Contact Information
Phase I and II trials for refractory cancers including medullary thyroid carcinoma:
With questions regarding these trials, please contact Ms. Alberta Aikin (phone: 301-496-0128, e-mail: aikina@mail.nih.gov), or Ms. Trish Whitcomb (phone: 301-496-0128, e-mail: whitcomt@mail.nih.gov).
Neurofibromatosis type 1 and 2 trials:
With questions regarding these trials please contact Ms. Andy Gillespie (phone: 301-402-1848, e-mail: gillesan@mail.nih.gov) or Ms. Andrea Baldwin (phone 201-594-9976, e-mail: baldwina@mail.nih.gov).
Children’s Oncology Group Phase I consortium trials:
With questions regarding these trials, please contact Ms. Anne Goodwin (phone: 301-594-4762, e-mail: goodwina@mail.nih.gov) or Ms. Wendy Goodspeed (phone 301-594-4762, e-mail: goodspew@mail.nih.gov).
This Page Last Reviewed on
February 26, 2013
About CCR | Clinical Trials | Research | Employment | Initiatives | News | Events | Site Privacy Policy | Accessibility
A Service of the National Cancer Institute
